Clinical Trials in Salt Lake City

Showing 5181-5200 of 12,670 trials

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT05359692

The purpose of this study is to determine the safety, tolerability, efficacy, PK and pharmacodynamics of INCAGN01876 when given in combination with retifanlimab. The study will consist of 2 parts: a safety lead-in part (Part 1) followed by a dose expansion part (Part 2).

Metastatic Head and Neck Squamous Cell CarcinomaAdvanced MalignanciesRecurrent Head and Neck Squamous Cell Carcinoma

Incyte Biosciences International SàrlStarted Mar 2023

Birmingham, Alabama, United States • La Jolla, California, United States • Palo Alto, California, United States +14 more locations

COMPLETEDPhase 3< 1 mile

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function

NCT02795676

This was a randomized, double-blind, active control study of the enzyme replacement therapy (ERT) drug PRX-102 (pegunigalsidase alfa) in Fabry disease patients with impaired renal function. Patients who had been treated for approximately 1 year with agalsidase beta and who had been on a stable dose of that product for at least 6 months were randomized in a 2:1 ratio to either switch to PRX-102 or to continue treatment with agalsidase beta. Both treatments were delivered by intravenous infusions every two weeks, at a dosage of 1 mg/kg.

Fabry Disease

Protalix78 participantsStarted Jun 2016

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Orange, California, United States +26 more locations

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function

Find Trials by Condition in Salt Lake City

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Addressing Dementia Via Agitation-Centered Evaluation

Human Epilepsy Project 2: Resistant Focal Seizures Study

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Multi-Center Pilot Study of Cutera truSculpt Device

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

Study of a Novel Laser for Skin Rejuvenation